Management of Sleep Disturbances in CKD Stage 5 on Hemodialysis

Immediate Dialysis Optimization

The American Society of Nephrology recommends verifying that patients with CKD stage 5 are receiving adequate hemodialysis frequency and duration, as inadequate dialysis is a primary driver of uremic symptoms including sleep disorders 2
The National Kidney Foundation suggests ensuring patients are dialyzing at least three times weekly for a minimum of 3 hours per session, as twice-weekly dialysis is only appropriate for patients with substantial residual kidney function 2
Consider extended or more frequent hemodialysis (4-6 times weekly) if sleep disturbances persist despite standard thrice-weekly dialysis, though evidence certainty is low 2
Calculate Kt/V to assess dialysis adequacy, targeting spKt/V ≥1.3 per dialysis session, as recommended by the American Journal of Kidney Diseases 3, 4

Screen for concurrent uremic symptoms that perpetuate insomnia using validated tools before initiating pharmacotherapy, as suggested by the American College of Physicians 2
Apply the Pittsburgh Sleep Quality Index (PSQI), where scores ≥5 indicate poor sleep quality, present in 65-83% of dialysis patients 2
Assess specifically for uremic pruritus, depression, restless legs syndrome, and pain, as these directly impair sleep, according to the American Academy of Sleep Medicine 1

The American College of Cardiology is not applicable here, however, the American Academy of Sleep Medicine recommends prescribing gabapentin 100-300 mg administered after each dialysis session as the preferred agent with proven efficacy and favorable safety profile 1, 2
Maximum daily dose should not exceed 200-300 mg in ESRD due to renal elimination, as recommended by the National Kidney Foundation 2

Consider ramelteon 8 mg at bedtime for refractory insomnia after optimizing dialysis and trying gabapentin, as suggested by the American College of Physicians 2
Avoid long-acting benzodiazepines due to accumulation risk and worsening cognitive function in patients already at risk for uremic encephalopathy, according to the American Geriatrics Society 2, 5

Implement cognitive behavioral therapy (CBT) when available, as it has proven efficacy in reducing depression and improving sleep in dialysis patients, as recommended by the American Psychological Association 1, 2
Prescribe aerobic exercise programs, which decrease depressive symptoms and may improve sleep quality with moderate certainty evidence, according to the American College of Sports Medicine 2

Evaluate medication efficacy and side effects at each dialysis visit using standardized tools like PSQI, as suggested by the American Society of Nephrology 1, 2
Monitor specifically for morning drowsiness, cognitive impairment, falls risk, and progression of neurologic symptoms, according to the American Academy of Neurology 2, 5

Escalate care immediately if sleep disturbance accompanies altered mental status or confusion, seizure activity, severe electrolyte abnormalities, volume overload refractory to current dialysis prescription, or progressive nutritional deterioration, as recommended by the American College of Emergency Physicians 2, 5

Do not rely solely on serum creatinine or urea nitrogen to assess adequacy; use validated GFR estimating equations or measured clearances, as recommended by the National Kidney Foundation 3, 4
Do not use sedating antihistamines long-term due to limited efficacy and increased dementia risk, according to the American Geriatrics Society 5